Makoto Misawa

Antitumor efficacy of oncolytic herpes simplex virus adsorbed onto antigen-specific lymphocytes

Y. Nishikawa, S. Yamada, T. Fujii, 2012, Cancer Gene Therapy.

A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer

S. Yamada, T. Fujii, H. Sugimoto, 2011, Cancer Gene Therapy.

Considerations for intravascular administration of oncolytic herpes virus for the treatment of multiple liver metastases

H. Sugimoto, S. Nomoto, A. Nakao, 2008, Cancer Chemotherapy and Pharmacology.

High therapeutic potential for systemic delivery of a liposome-conjugated herpes simplex virus.

Y. Nishikawa, S. Yamada, T. Fujii, 2011, Current cancer drug targets.